
Quarterly report 2025-Q3
added 11-25-2025
Medtronic PLC EPS Ratio 2011-2025 | MDT
EPS is a measure used to assess the financial stability and profitability of a company. EPS (Earnings Per Share) represents the company's net income divided by the number of its outstanding shares. This measure allows investors and analysts to evaluate the return on investment in the company's stock and compare it to other companies in the industry.
The term earnings per share (EPS) represents the portion of a company's earnings, net of taxes and preferred stock dividends, that is allocated to each share of common stock. The figure can be calculated simply by dividing net income earned in a given reporting period (usually quarterly or annually) by the total number of shares outstanding during the same term. Because the number of shares outstanding can fluctuate, a weighted average is typically used.
Calculated as:
EPS = (Net Income - Dividends on Preffered Stock) / Average Outstanding shares[1]
EPS can be calculated as a simple ratio of net income to shares, or in various variations, such as diluted EPS, which takes into account the potential issuance of new shares or convertible securities.
A high EPS ratio usually indicates that the company has good profitability and efficiency in utilizing its assets. However, other factors such as sales growth, debt burden, and the company's competitive position should also be considered.
EPS ratio is an important indicator for investors when making decisions to buy or sell a company's stock. It is also used by analysts to assess the financial condition of the company and its potential for growth and development.
Annual EPS Ratio Medtronic PLC
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.63 | 2.77 | 2.83 | 3.75 | 2.68 | 3.57 | 3.44 | 2.29 | 2.92 | 2.51 | 2.44 | 3.06 | 3.4 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.75 | 2.29 | 3.02 |
Quarterly EPS Ratio Medtronic PLC
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.07 | 0.81 | - | 1.01 | 0.99 | 0.81 | - | 0.99 | 0.68 | 0.59 | - | 0.92 | 0.32 | 0.7 | - | 0.94 | 0.97 | 1.54 | - | 1.43 | 0.36 | 0.36 | 0.36 | 0.95 | 1.02 | 1.02 | 0.64 | -1.03 | 0.83 | 0.83 | 0.79 | 0.6 | 1.49 | 1.49 | 0.75 | 0.78 | 0.81 | 0.81 | 0.67 | 0.99 | 0.37 | 0.37 | 0.58 | 0.76 | 0.84 | 0.88 | 0.45 | - | 0.9 | 0.94 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.54 | -1.03 | 0.781 |
References
- Khan, T. R., Islam, M. R., Choudhury, T. T., & Adnan, A. M. (2014). How earning per share (EPS) affects on share price and firm value.
EPS Ratio of other stocks in the Medical devices industry
| Issuer | EPS Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Abiomed
ABMD
|
5 | - | - | $ 17.2 B | ||
|
AdaptHealth Corp.
AHCO
|
0.62 | $ 9.47 | -2.87 % | $ 1.27 B | ||
|
Avinger
AVGR
|
-23.3 | - | -20.74 % | $ 369 K | ||
|
Aziyo Biologics
AZYO
|
-2.07 | - | 1.37 % | $ 20.5 M | ||
|
BIOLASE
BIOL
|
-29.4 | - | -13.19 % | $ 166 K | ||
|
BioSig Technologies
BSGM
|
-0.75 | - | 37.08 % | $ 85.7 M | ||
|
Conformis
CFMS
|
-6.99 | - | - | $ 16.4 M | ||
|
Butterfly Network
BFLY
|
-0.34 | $ 2.75 | -1.79 % | $ 582 M | ||
|
Acutus Medical
AFIB
|
-2.81 | - | -26.83 % | $ 2.62 M | ||
|
Delcath Systems
DCTH
|
-0.93 | $ 9.32 | -2.71 % | $ 266 M | ||
|
Dynatronics Corporation
DYNT
|
-1.43 | - | 14.99 % | $ 929 K | ||
|
Allied Healthcare Products
AHPI
|
-0.48 | - | 3.58 % | $ 2.21 M | ||
|
Electromed
ELMD
|
0.89 | $ 27.6 | 0.66 % | $ 233 M | ||
|
Establishment Labs Holdings
ESTA
|
-3 | $ 68.04 | 0.37 % | $ 1.92 B | ||
|
Second Sight Medical Products
EYES
|
-0.43 | - | -0.97 % | $ 54.4 M | ||
|
FONAR Corporation
FONR
|
1.78 | $ 14.36 | 0.97 % | $ 94.1 M | ||
|
GBS
GBS
|
-2 | - | -0.57 % | $ 7.12 M | ||
|
Abbott Laboratories
ABT
|
7.67 | $ 126.4 | -1.3 % | $ 220 B | ||
|
Bruker Corporation
BRKR
|
0.76 | $ 47.91 | 0.1 % | $ 7.14 K | ||
|
Globus Medical
GMED
|
0.76 | $ 89.76 | -0.09 % | $ 12.2 B | ||
|
Boston Scientific Corporation
BSX
|
1.26 | $ 99.38 | -1.65 % | $ 146 B | ||
|
Helius Medical Technologies
HSDT
|
-14.6 | $ 4.11 | 9.77 % | $ 2.5 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
-0.09 | $ 13.33 | 2.05 % | $ 1.03 B | ||
|
Apollo Endosurgery
APEN
|
-0.98 | - | - | $ 475 M | ||
|
Apyx Medical Corporation
APYX
|
-0.54 | $ 4.09 | 1.74 % | $ 142 M | ||
|
Accuray Incorporated
ARAY
|
-0.02 | $ 1.03 | 1.47 % | $ 106 M | ||
|
Inogen
INGN
|
-1.52 | $ 6.77 | -2.66 % | $ 160 M | ||
|
IRIDEX Corporation
IRIX
|
-0.59 | $ 0.91 | -2.0 % | $ 14.7 M | ||
|
IRadimed Corporation
IRMD
|
1.52 | $ 92.81 | 0.54 % | $ 1.18 B | ||
|
Integer Holdings Corporation
ITGR
|
3.57 | $ 70.25 | -2.08 % | $ 2.36 B | ||
|
Align Technology
ALGN
|
5.63 | $ 150.68 | 2.7 % | $ 11.3 B | ||
|
OrthoPediatrics Corp.
KIDS
|
-1.64 | $ 17.8 | -0.78 % | $ 411 M | ||
|
LivaNova PLC
LIVN
|
1.17 | $ 63.67 | 0.89 % | $ 3.45 B | ||
|
Cognyte Software Ltd.
CGNT
|
-0.17 | $ 8.41 | 3.19 % | $ 604 M | ||
|
LENSAR
LNSR
|
-2.73 | $ 10.32 | 0.68 % | $ 119 M | ||
|
AxoGen
AXGN
|
-0.23 | $ 27.83 | -2.47 % | $ 1.23 B | ||
|
Axonics Modulation Technologies
AXNX
|
-1.28 | - | - | $ 3.31 B | ||
|
Pulmonx Corporation
LUNG
|
-1.44 | $ 1.79 | 1.7 % | $ 70 M | ||
|
Alphatec Holdings
ATEC
|
-1.13 | $ 21.42 | -2.46 % | $ 3.06 B | ||
|
Medigus Ltd.
MDGS
|
0.01 | - | 10.28 % | $ 55.5 M | ||
|
MiMedx Group
MDXG
|
0.29 | $ 6.73 | 0.9 % | $ 989 M | ||
|
ClearPoint Neuro
CLPT
|
-0.7 | $ 13.46 | -2.07 % | $ 364 M | ||
|
CONMED Corporation
CNMD
|
4.29 | $ 44.44 | -0.16 % | $ 1.37 B | ||
|
Myomo
MYO
|
-1.52 | $ 0.89 | -0.46 % | $ 6.28 M | ||
|
Inari Medical
NARI
|
-0.55 | - | - | $ 4.23 B | ||
|
Aethlon Medical
AEMD
|
-8.58 | $ 4.82 | 14.37 % | $ 7.52 M | ||
|
Nemaura Medical
NMRD
|
-0.57 | - | -17.8 % | $ 2.74 M |